The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth advocates argue that two of these rules hinder access to care.
MedCity News is a trusted source for comprehensive coverage and analysis of the rapidly evolving healthcare innovation landscape. As the industry shifts towards value-based care, MedCity News provides in-depth reporting on how various stakeholders, including payers, providers, healthtech startups, investors, medtech companies, diagnostics firms, and biopharma organizations, are striving to improve patient outcomes while reducing costs.
The platform's audience primarily consists of busy professionals and senior executives in the healthcare ecosystem who seek to stay informed about the latest trends, developments, and challenges in areas such as chronic disease management, cancer care, remote patient monitoring, and clinical workflow optimization. MedCity News goes beyond press releases to deliver insightful analysis and explanations of how emerging technologies, such as artificial intelligence, are reshaping healthcare delivery.
In addition to its news coverage, MedCity News organizes events that bring together key industry players to share insights and explore opportunities and challenges. The platform also offers two distinct programs: MedCitizens, a community for healthcare startups to showcase their innovations, and MedCity Influencers, a platform for experienced professionals and executives to share thought leadership and opinions.
MedCity News distributes its content through various channels, including a daily newsletter that highlights the day's top stories, a weekly biopharma newsletter (BioPulse), and a newsletter focused on updates from MedCitizens (StartUPDATES). Its coverage spans a wide range of themes, including healthcare and pharmaceuticals, health and wellbeing, data and analytics, human resources and employment, and scientific advancements.